The Mark Foundation for Cancer Research (MFCR) shared on X:
“Thinking about applying for a TBXT and Beyond ASPIRE Award?
With our partners at the Chordoma Foundation, we are hosting an informal informational webinar on November 12 to share more details about this grant opportunity focused on expanding the chordoma surface.
About the Research Opportunity
The funding opportunity supports research aimed at identifying and developing new therapeutic targets on the surface of chordoma cells, with a particular focus on TBXT-derived peptide-MHC (pMHC) complexes and other tumor-specific surface antigens.
Eligible independent researchers at nonprofit academic or research institutions, including those outside the United States, may request up to $500,000 for projects lasting up to 24 months. Proposals may focus on basic and translational research, preclinical proof-of-concept studies, and the development of tools, technologies, and datasets to advance surface-targeted therapies.
Key application deadlines:
December 10, 2026: Concept letters due by 5:00 PM ET.
End of January 2027: Full applications invited.
March 1, 2027: Full applications due.
June 1, 2027: Expected grant start date.
Read the full request for proposals and eligibility criteria.
Check out PSONS Career Development Scholarship for Nurse Managers 2027 and other grant opportunities on OncoDaily.
